Condition (MeSH)
Coronary Vessel Anomalies
ClinicalTrials.gov lists 12 trials for Coronary Vessel Anomalies or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
1 of the 12 trials are tagged with Coronary Vessel Anomalies itself; the rest are tagged with a narrower condition beneath it.
When did Coronary Vessel Anomalies trials start? (10)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Phase 4
- Not applicable
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2023 | 1 |
| 2022 | 1 |
| 2021 | 1 |
| 2020 | 2 |
| 2018 | 1 |
| 2017 | 1 |
| 2016 | 1 |
| 2014 | 1 |
| 2009 | 2 |
| 2004 | 1 |
No forecast is made for this condition: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Coronary Vessel Anomalies trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 1 |
| Phase 4 | 1 |
| Not applicable | 2 |
| Observational | 8 |
How many Coronary Vessel Anomalies trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 2 |
| Completed | 7 |
| Terminated | 2 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which drugs are being tested for Coronary Vessel Anomalies? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| NEBIVOLOL | 1 |
Interventions as named in the registry (1)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| 2% Diltiazem | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Coronary Vessel Anomalies? (112)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Remotely delivered mindfulness-based cognitive therapy for spontaneous coronary artery dissection survivors. | Translational behavioral medicine | 2025 | Yes |
| Posttraumatic Stress Disorder After Spontaneous Coronary Artery Dissection: A Report of the International Spontaneous Coronary Artery Dissection Registry. | Journal of the American Heart Association | 2024 | Yes |
| Clinical characteristics and outcomes of patients with takotsubo syndrome versus spontaneous coronary artery dissection. | Cardiology journal | 2023 | Yes |
| Association of Spontaneous Coronary Artery Dissection With Atrial Arrhythmias. | The American journal of cardiology | 2023 | Yes |
| Clinical implications of arterial hypertension in patients with spontaneous coronary artery dissection. | Coronary artery disease | 2022 | Yes |
Showing 5 of 112 publications.
Sub-conditions in MeSH (2)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, and rare-disease identity.